Socorro ISD earns district certification from National Institute for STEM Education
EL PASO, Texas (KTSM) — The Socorro Independent School District said it is the most recent district in the country to earn the National Certificate for STEM Excellence – District (NCSE-D) STEM certificate.
Socorro ISD announced the recognition on Tuesday, May 27, in a news release.
Socorro ISD said the district is the first in West Texas and one of only three in Texas in the nation to earn the district STEM certification.
The certificate, which comes from the National Institute for STEM Education (NISE), recognizes districts for their commitment to continually improving districtwide systems and structures that support STEM educators and their students, Socorro ISD said.
'We are extremely honored to earn the national STEM certification, which validates the hard work and dedication among our faculty, staff and administrators to ensure that our students are receiving meaningful instruction and hands-on experience in science, technology, engineering and math,' Socorro ISD Interim Superintendent James Vasquez said. 'Our highly qualified teachers, campus and district leaders are achieving outstanding results integrating STEM instruction across all areas of student learning.'
Socorro ISD said NISE, which is headquartered in Houston, Texas, was conceived by seasoned, practicing educators and is based on thousands of hours of research, professional development, curriculum design, and educational leadership.
Using an online platform and supported by a dedicated NISE STEM leadership coach, educators and district leaders work together to refine district operations and instruction to further strengthen STEM practices and the district's overall STEM culture, Socorro ISD added.
Socorro ISD said that as part of earning the NCSE – District Certification, along with over two years of sustained visioning, planning, and implementing STEM education system, three campuses also earned the NCSE – Campus Certification, and 97 teachers and administrators earned the National Certificate for STEM Teaching (NCST).
Escontrias STEAM Academy was the first school in West Texas to earn the National Certificate for STEM Excellence – Campus Certification in July 2023, the district said.
The district added that Sierra Vista STEAM Academy earned the certification in August 2024, and Montwood High School earned the certification in January 2025.
'I commend the district academics team and our STEM-certified schools who worked diligently to make this national certification a reality for our students and district,' Vasquez said. 'It demonstrates that SISD is a leader in STEM education dedicated to providing students the knowledge, skills and resources to excel in our competitive, science and technology-based society.'
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
Is Now a Good Time to Buy Quantum Computing Stocks? History Suggests What Could Happen Next.
Quantum computing has emerged as one of the hottest areas in the artificial intelligence (AI) realm. While IonQ, Rigetti, and D-Wave Quantum all have momentum fueling their share prices, valuation trends suggest that these stocks may be in a bubble. History suggests that a precipitous sell-off could be in store for emerging companies fueling the quantum computing opportunity. 10 stocks we like better than Rigetti Computing › While there have been fleeting moments of euphoria in the stock market in 2025, it's been a pretty tough year overall. One particular area that has managed to outmaneuver this year's volatility, however, is quantum computing. As of the closing bell on May 27, the Defiance Quantum ETF had returned approximately 8% so far t his year -- handily outperforming the returns of the S&P 500, Nasdaq Composite, and Dow Jones Industrial Average. Given those dynamics, investors might be tempted to start buying quantum computing stocks right now. Among the most popular names fueling the gains in the Defiance Quantum exchange-traded fund are IonQ (NYSE: IONQ), Rigetti Computing (NASDAQ: RGTI), and D-Wave Quantum (NYSE: QBTS). Let's assess what is fueling the excitement around quantum computing at the moment. From there, I'll dig into valuation trends for the companies referenced above to help determine if now is a good opportunity to own these market-beating stocks. While artificial intelligence (AI) has become a megatrend fueling the stock market to new highs over the last couple of years, I would argue that there is a finite number of end markets contributing to the industry's popularity. What I mean by that is that within the AI realm, areas such as semiconductors, cloud computing, and enterprise software seem to fetch the most enthusiasm. I think this is why chip stocks such as Nvidia, software players like Palantir Technologies, and cloud hyperscalers Microsoft, Amazon, and Alphabet have consistently remained high-profile names pushing the AI narrative forward. In my eyes, investors may be getting a little tired of seeing the same names affiliated with AI opportunities. Perhaps this is why quantum computing -- which can complete mathematical calculations exponentially faster than existing methods of computing -- has started to emerge as a potential "next big thing" in the AI landscape. Despite little commercial scale, the total addressable market (TAM) for quantum computing is expected to be in the hundreds of billions of dollars, according to estimates compiled by management consulting firm McKinsey & Company. The chart below illustrates the price-to-sales (P/S) ratio for IonQ, Rigetti Computing, and D-Wave Quantum over the past year. The most obvious takeaway from these trends is that the soaring share prices have resulted in pronounced levels of valuation expansion. But considering how game-changing quantum computing might be for the AI movement, shouldn't investors look past these valuation multiples? Unfortunately, I think the answer to that is a hard "no." To add some context to the multiples above, consider that the P/S ratios of Amazon and Cisco topped out between 30 and 40 during the peak days of the dot-com bubble. When you assess IonQ and its peers through that lens, the P/S levels above look unsustainable. Below, investors can see that over the past two decades, the P/S ratios for Cisco, Amazon, and even Nvidia have compressed considerably. These dynamics make sense. As businesses mature and diversify their products and services, they (hopefully) achieve a path to consistent profitability and begin to be valued based on earnings and cash flow as opposed to revenue. What makes investing in IonQ, Rigetti, and D-Wave Quantum riskier than, say, Amazon and Cisco 20 years ago or Nvidia right now, is that, collectively, these quantum computing companies are only generating tens of millions in revenue while burning hundreds of millions of dollars annually. A financial profile like that makes reaching profitability and scaling a business an uphill battle. While history is not guaranteed to repeat itself, I think it is highly likely that shares of IonQ, Rigetti, and D-Wave will begin to witness some pressure sooner than later. As a result, there could be extreme levels of compression in valuation multiples. Ultimately, I think the quantum computing stocks I've talked about here are speculative. They're geared more for day traders and less appealing for investors with a long-run horizon. I would pass on IonQ, Rigetti, and D-Wave Quantum and prefer to continue investing in megacap technology stocks going forward. Their diversified business models are more appealing and provide them with the financial flexibility to explore quantum computing if they choose to do so down the road. Before you buy stock in Rigetti Computing, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Rigetti Computing wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $657,385!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $842,015!* Now, it's worth noting Stock Advisor's total average return is 987% — a market-crushing outperformance compared to 171% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 2, 2025 John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool's board of directors. Adam Spatacco has positions in Alphabet, Amazon, Microsoft, Nvidia, and Palantir Technologies. The Motley Fool has positions in and recommends Alphabet, Amazon, Cisco Systems, Microsoft, Nvidia, and Palantir Technologies. The Motley Fool recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy. Is Now a Good Time to Buy Quantum Computing Stocks? History Suggests What Could Happen Next. was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Axios
7 hours ago
- Axios
Elon Musk gives Dems new anti-Trump ammo
Elon Musk's brutal attacks Tuesday on President Trump's "One Big, Beautiful Bill" instantly became a centerpiece of Democratic messaging. Why it matters: The recently departed Trump lieutenant blasted the bill as a "disgusting abomination" as Trump and GOP leaders are struggling to get it across the finish line in the Senate. To House Democrats' glee, Musk's broadside comes after nearly all House Republicans voted for the legislation in its current form. "It's very disappointing," House Speaker Mike Johnoson (R-La.) told reporters. Driving the news: " I'm sorry, but I just can't stand it anymore," Musk said in a post on his social media site X. "This massive, outrageous, pork-filled Congressional spending bill is a disgusting abomination. Shame on those who voted for it: you know you did wrong. You know it." Democrats quickly pounced on the comments, with House Minority Leader Hakeem Jeffries (D-N.Y.) expounding upon them at length at a press conference where he displayed a blown-up graphic of Musk's post. "Breaking news. Elon Musk and I agree with each other," Jeffries said. "Every single Republican who voted for the One Big Ugly Bill should be ashamed of themselves." "We're happy to see that Elon agrees with us that every Republican who voted for the tax scam should lose their job," said Democratic Congressional Campaign Committee spokesperson Viet Shelton. The other side: Johnson told reporters he and Musk had a "long conversation" Tuesday and described the billionaire tech entrepreneur as a "very good friend" but said he is "terribly wrong" about the bill. "He and I spoke for, I think, more than 20 minutes on the telephone, and I extolled all the virtues of the bill. And he seemed to understand that," Johnson said, calling Musk's opposition "surprising" in light of that call. Johnson speculated that the bill's phase-out of electric vehicle tax credits — which benefit Musk's car company, Tesla — could be a factor. Yes, but: The handful of hardline fiscal conservatives in Congress who staunchly oppose the Republican bill were quick to endorse Musk's message.
Yahoo
11 hours ago
- Yahoo
Streck releases improved ARM-D® Kit, OXA with expanded coverage in three new OXA gene families
LA VISTA, Neb., June 3, 2025 /PRNewswire/ -- Streck is excited to announce the release of an updated version of the Streck ARM-D® Kit, OXA that detects an additional 36 allelic variants in 3 new antimicrobial resistance (AR) gene families. This expanded coverage is in response to customer feedback, particularly the member laboratories of the Antimicrobial Resistance Laboratory Network (ARLN) and the Centers for Disease Control and Prevention (CDC), who have identified gene families and allelic variants of increasing diversity and relevance and require a surveillance method that can effectively detect them. Of particular interest to these labs is effective detection of the variants of OXA-235, OXA-236 and OXA-237 in the OXA-134 family, as well as OXA-327-like and OXA-198-like beta-lactamase enzymes. "The expansion of the Streck ARM-D Kit, OXA demonstrates our dedication to ensuring our products meet the needs of our customers in public health laboratories and emphasizes our commitment to make a global impact through solutions that improve infectious disease testing strategies," said Chris Connelly, director of Business Segment – Molecular. "We're proud to be a trusted resource for laboratories working hard in the fight against antimicrobial resistance." Streck's ARM-D kits allow for the cost-effective and comprehensive detection of more than 2,000 allelic variants across 25 AR gene families. Results from the kits demonstrate 100% concordance with whole genome sequencing (WGS) data from the same samples, for the targeted AR variants. The ARM-D kits are often used as a pre-WGS screening method to reduce the cost of AR surveillance in public health laboratories in the United States and other parts of the world. Streck ARM-D Kit, OXA is For Research Use Only. Not for use in diagnostic procedures. About Streck, in 1971, Streck provides solutions that ensure every result counts by empowering clinical and research laboratories to reliably deliver accurate results, advance diagnostics and enable healthier, happier lives for patients everywhere. Streck products are manufactured in La Vista, Nebraska, and delivered to thousands of labs worldwide. Contact: Chris Connelly, Director of Business Segment - MolecularCConnelly@ View original content to download multimedia: SOURCE Streck Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data